NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)

Clinical trial NCT05996003 · RECRUITING

Trial details

NCT number: NCT05996003
Sponsor: NS Pharma, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Duchenne Muscular Dystrophy Exon 44 DMD

Start date: 2024-02-22
Primary completion: 2026-09-11
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.